Skip to main content

Advertisement

SpringerLink
Log in

Examining the link between TNF inhibition and alopecia areata using Mendelian randomization

  • Letters of Biomedical and Clinical Research
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Data availability

All summary statistics used in this study are publicly available, with relevant citations detailed.

References

  1. FDA Adverse Events Reporting System (FAERS) Public dashboard - FDA adverse events reporting system (FAERS) public dashboard. [cited 2023 Jun 21]; Available from: https://fis.fda.gov/

  2. Béné J, Moulis G, Auffret M, Lefevre G, Coquerelle P, Coupe P et al (2014) Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Rheumatology 53:1465–1469

    Article  PubMed  Google Scholar 

  3. Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD et al (2014) Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study. J Am Acad Dermatol 70:1146–1149

    Article  PubMed  Google Scholar 

  4. Gorcey L, Gordon Spratt EA, Leger MC (2014) Alopecia universalis successfully treated with adalimumab. JAMA Dermatol 150:1341–1344

    Article  PubMed  Google Scholar 

  5. Pugliese D, Guidi L, Ferraro PM, Marzo M, Felice C, Celleno L et al (2015) Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther 42:880–888

    Article  CAS  PubMed  Google Scholar 

  6. Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F et al (2012) TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488:508–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. FinnGen. Access results. [cited 2023 May 26]; Available from: https://www.finngen.fi/en/access_results

Download references

Funding

SSZ is supported by a National Institute for Health Research (NIHR) Academic Clinical Lectureship. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. This work was supported by Versus Arthritis (grant number 21173, 21754, 21755).

Author information

Authors and Affiliations

  1. Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9LJ, UK

    Sizheng Steven Zhao

Authors
  1. Sizheng Steven Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sizheng Steven Zhao.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, S.S. Examining the link between TNF inhibition and alopecia areata using Mendelian randomization. Clin Rheumatol 43, 819–820 (2024). https://doi.org/10.1007/s10067-023-06734-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06734-1

Search

Navigation